The Federal Trade Commission (FTC) is opening an investigation into the business practices of pharmacy benefit managers (PBMs). PBMs have been in the hotseat for quite some time. Executives from the largest PBMs were recently called to testify before Congress to explain whether their business practices lead to higher drug prices. In the latest inquiry, the FTC announced it will require the six largest PBMs to provide a range of information and business records on operations.
Category: Policy & Legislation
Who Does the AARP Represent?
The AARP, the legendary advocacy for seniors aged 50 and above, has come under increased scrutiny in recent years for its marketing partnerships. Much of AARP’s revenue comes from licensing its name and logo to sell a wide range of goods and services targeted to seniors. The AARP is undoubtedly a senior advocacy, but it is also a marketing juggernaut that sells insurance.
Friday Links – 3 June 2022
- Biden wants to reinstate the airplane mask mandate.
- AMA wants physician pay reform: inflation indexing, but no HSA expansion or price transparency.
- JAMA: hospitals are marking up the cost of cancer drugs by as much as 634%.
- Three ways the government caused the baby formula shortage.
- The Covid Health Emergency is over, but politics and pork are keeping it going.